- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07623070
Gac Fruit Oil Supplementation for Visual Health and Sleep Quality
28. maj 2026 opdateret af: Yuanpei University of Medical Technology
Study on Visual Health Promotion and Carotenoids From Momordica Cochinchinensis
This study evaluated the effects of gac fruit oil supplementation on visual health, sleep quality, depressive symptoms, cognitive function, and brain imaging parameters in adults with sleep disturbance.
Participants aged 40 to 65 years were recruited and received gac fruit oil capsules for 30 days.
The supplementation protocol consisted of two capsules in the morning and two capsules in the evening each day.
Assessments were performed before and after the intervention, including macular pigment measurement, ocular surface disease evaluation, tear film analysis, contrast sensitivity testing, accommodative microfluctuation analysis, optical coherence tomography, the Pittsburgh Sleep Quality Index, a depression scale, the Mini-Mental State Examination, and brain magnetic resonance imaging.
The study aimed to explore whether 30 days of gac fruit oil supplementation was associated with changes in visual function, sleep quality, mood-related measures, cognitive function, and brain imaging findings.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
50
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Hsinchu, Taiwan, 30015
- Yuanpei University of Medical Technology
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Adults aged 40 to 65 years.
- Participants with sleep disturbance.
- Participants who were willing to participate in the study and provide written informed consent.
Exclusion Criteria:
- History of ocular surgery.
- Cataract.
- Glaucoma.
- Current supplementation intended to increase macular pigment level.
- Pregnancy.
- Severe illness.
- Use of medications that may affect or stimulate sleep.
- Use of medications that promote sleep.
- Unable to undergo magnetic resonance imaging, including but not limited to individuals with a pacemaker, artificial heart valve, metal aneurysm clip, metallic tracheostomy tube, possible metallic fragments in the orbit, cochlear implant, implanted electrodes, neurostimulator, implanted drug infusion device, hemostatic clips, vascular stents, claustrophobia, previous brain surgery, or history of traumatic brain injury with implanted metal materials.
- Participants who experienced discomfort during the study or wished to withdraw could discontinue participation at any time without providing a reason.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Gac Fruit Oil Supplementation
Participants received gac fruit oil capsules for 30 days.
The supplementation protocol consisted of two capsules in the morning and two capsules in the evening each day.
|
Participants took gac fruit oil capsules orally for 30 days.
The supplementation protocol consisted of two capsules in the morning and two capsules in the evening each day, for a total of four capsules per day.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Sleep Quality
Tidsramme: Baseline and 30 days
|
Sleep quality was assessed using the Pittsburgh Sleep Quality Index before and after 30 days of gac fruit oil supplementation.
|
Baseline and 30 days
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Depressive Symptoms
Tidsramme: Baseline and 30 days
|
Depressive symptoms were assessed using a depression scale before and after 30 days of gac fruit oil supplementation.
|
Baseline and 30 days
|
|
Change in Macular Pigment Level
Tidsramme: Baseline and 30 days
|
Macular pigment level was assessed using a macular pigment screener before and after 30 days of gac fruit oil supplementation.
|
Baseline and 30 days
|
|
Change in Ocular Surface Disease Symptoms
Tidsramme: Baseline and 30 days
|
Ocular surface disease symptoms were assessed using the Ocular Surface Disease Index before and after 30 days of gac fruit oil supplementation.
|
Baseline and 30 days
|
|
Change in Tear Film Parameters
Tidsramme: Baseline and 30 days
|
Tear film parameters were assessed using a non-contact ocular surface analyzer before and after 30 days of gac fruit oil supplementation.
|
Baseline and 30 days
|
|
Change in Contrast Sensitivity
Tidsramme: Baseline and 30 days
|
Contrast sensitivity was assessed using the CVS-1000 contrast sensitivity test before and after 30 days of gac fruit oil supplementation.
|
Baseline and 30 days
|
|
Change in Accommodative Microfluctuation
Tidsramme: Baseline and 30 days
|
Accommodative microfluctuation was assessed using an accommodative microfluctuation analyzer before and after 30 days of gac fruit oil supplementation.
|
Baseline and 30 days
|
|
Change in Retinal Structure
Tidsramme: Baseline and 30 days
|
Retinal structure was assessed using optical coherence tomography before and after 30 days of gac fruit oil supplementation.
|
Baseline and 30 days
|
|
Change in Cognitive Function
Tidsramme: Baseline and 30 days
|
Cognitive function was assessed using the Mini-Mental State Examination before and after 30 days of gac fruit oil supplementation.
|
Baseline and 30 days
|
|
Change in Brain Magnetic Resonance Imaging Parameters
Tidsramme: Baseline and 30 days
|
Brain magnetic resonance imaging parameters were assessed before and after 30 days of gac fruit oil supplementation.
|
Baseline and 30 days
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Ledende efterforsker: Chao-Kai Chang, Yuanpei University of Medical Technology
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. september 2022
Primær færdiggørelse (Faktiske)
16. juli 2023
Studieafslutning (Faktiske)
16. juli 2023
Datoer for studieregistrering
Først indsendt
28. maj 2026
Først indsendt, der opfyldte QC-kriterier
28. maj 2026
Først opslået (Faktiske)
3. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
3. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
28. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- YPU-IRB-1110708
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
Individual participant data will not be shared because the study data include health-related questionnaire responses, ophthalmic examination data, and brain magnetic resonance imaging data.
Data were collected under the informed consent and confidentiality procedures approved by the institutional review board.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Søvnforstyrrelser
-
University of Wisconsin, MadisonPhilips HealthcareAfsluttetSøvn, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
Nutrition Institute, SloveniaValens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... og andre samarbejdspartnereRekrutteringSøvnkvalitet | Sleep Onset LatencySlovenien
-
Mahidol UniversityRamathibodi HospitalIkke rekrutterer endnuSøvninerti | Søvn, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization | NatskiftarbejdeThailand
-
University of ArizonaNational Heart, Lung, and Blood Institute (NHLBI)Ikke rekrutterer endnu
-
Haseki Training and Research HospitalIkke rekrutterer endnuRichards-Campbell Sleep Questionnaire (RCSQ)
-
National University of SingaporeRekrutteringReduktion af skærmbrug + Sleep Extension | Frit levendeSingapore
-
The First Affiliated Hospital of Shanxi Medical...Shanxi Medical UniversityAfsluttetSøvnkvalitet | Søvnvarighed | Sleep Onset LatencyKina
-
Institute of Nutrition, Slovenia (Nutris)Valens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... og andre samarbejdspartnereIkke rekrutterer endnuSøvnkvalitet | Sleep Onset LatencySlovenien
-
Fu Jen Catholic University HospitalIkke rekrutterer endnuSedation | DISE | OSAS (Obstructive Sleep Apneas Syndrome)Taiwan